You are here

Home

Clinical Trials: Musculoskeletal Disease

Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: Monday, May 21, 2012 - 12:00
BOTOX® Open-Label Treatment in Pediatric Lower Limb Spasticity
Conditions:   Pediatrics;   Muscle Spasticity;   Cerebral Palsy
Intervention:   Biological: botulinum toxin Type A
Sponsor:   Allergan
Recruiting - verified March 2016
Posted: Monday, May 21, 2012 - 12:00
BOTOX® Treatment in Pediatric Upper Limb Spasticity
Conditions:   Pediatrics;   Muscle Spasticity;   Cerebral Palsy;   Stroke
Interventions:   Biological: botulinum toxin Type A;   Biological: botulinum toxin Type A;   Drug: Normal Saline (Placebo)
Sponsor:   Allergan
Recruiting - verified March 2016
Posted: Monday, May 21, 2012 - 12:00
BOTOX® Open-Label Treatment in Pediatric Upper Limb Spasticity
Conditions:   Pediatrics;   Muscle Spasticity;   Cerebral Palsy;   Stroke
Intervention:   Biological: botulinum toxin Type A
Sponsor:   Allergan
Recruiting - verified March 2016
Posted: Thursday, March 8, 2012 - 12:00
Safety Study of Mesenchymal Stem Cells and Spinal Fusion
Conditions:   Lumbar Spondylolisthesis Involving L4-L5, and/or;   Degenerative Discopathy Involving L4-L5
Interventions:   Biological: XCEL-MT-OSTEO-ALPHA;   Procedure: Standard treatment
Sponsors:   Banc de Sang i Teixits;   TFS Trial Form Support;   Ministerio de Sanidad, Servicios Sociales e Igualdad;   Ministerio de Ciencia e Innovación, Spain
Recruiting - verified November 2015

Pages